⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Official Title: A Randomized, Placebo Controlled Study to Determine the Effect of Two Dose Schedules of R1507 or Placebo, Both in Combination With Erlotinib (Tarceva®), on Progression-free Survival in Patients With Advanced Non-small Cell Lung Cancer With Disease Progression After First or Second Line Chemotherapy

Study ID: NCT00760929

Study Description

Brief Summary: This 4 arm study in patients with advanced Stage IIIb/IV non-small cell cancer (NSCLC) who failed at least one standard chemotherapy regimen will determine the proportion of patients with progression-free survival at 12 weeks following combination therapy with R1507 and Tarceva or placebo and Tarceva. Patients will be randomized to one of four treatment arms to receive R1507 (9mg/kg iv) or placebo weekly or R1507 (16mg/kg iv) or placebo every 3 weeks. Tarceva (150mg oral daily) will be administered in all treatment arms. Other disease-related endpoints including overall survival, objective response rate, time to response, time to progressive disease and duration of response will also be evaluated. The anticipated time on study treatment is 1-2 years, and the target sample size is \<500 individuals.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Tower Cancer Research Foundation, Beverly Hills, California, United States

Florida Cancer Inst., New Port Richey, Florida, United States

Emory Univ Winship Cancer Inst, Atlanta, Georgia, United States

University of Chicago Medical Center; Dept. of Medicine/Section of Nephrology, Chicago, Illinois, United States

North Shore University Health System, Glenview, Illinois, United States

Joliet Oncology Hematology Associates, Ltd., Joliet, Illinois, United States

St. Joseph Medical Center, Towson, Maryland, United States

Massachusetts General Hospital., Boston, Massachusetts, United States

Dana Farber Cancer Inst., Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

Carolina Oncology Specialists, PA - Hickory, Hickory, North Carolina, United States

Chattanooga Oncology and Hematology Associates, PC, Chattanooga, Tennessee, United States

Sarah Cannon Research Inst., Nashville, Tennessee, United States

Virginia Cancer Institute, Richmond, Virginia, United States

Flinders Medical Center; Medical Oncology, Adelaide, South Australia, Australia

Frankston Hospital; Oncology/Haematology, Frankston, Victoria, Australia

Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

Cliniques Universitaires St-Luc, Bruxelles, , Belgium

GHdC Site Notre Dame, Charleroi, , Belgium

UZ Antwerpen, Edegem, , Belgium

UZ Leuven Gasthuisberg, Leuven, , Belgium

Chr de La Citadelle, Liege, , Belgium

Lakeridge Health Oshawa; Oncology, Oshawa, Ontario, Canada

Hopital Albert Michallon; Medecine Aigue Specialisee Pneumologie, La Tronche, , France

Hopital de La Croix Rousse; Service de Pneumologie, Lyon, , France

Fondation Hopital Saint Joseph; Pole Cancerologie, Imagerie Medicale Service d'Oncologie, Paris, , France

Hopital Tenon;Pneumologie, Paris, , France

Hopital Larrey; Clinique Des Voies Respiratoires, Toulouse, , France

Zentralklinik Bad Berka GmbH; Pneumologie, Bad Berka, , Germany

Helios Klinikum Emil von Behring GmbH, Berlin, , Germany

LungenClinic Großhansdorf GmbH, Großhansdorf, , Germany

Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I, Halle (Saale), , Germany

Asklepios Klinik Harburg; Thoraxzentrum, Hamburg, , Germany

Thoraxklinik Heidelberg gGmbH, Heidelberg, , Germany

Stiftung Kathol. Krankenhaus Marienhospital Herne Klinik Mitte Frauenklinik, Herne, , Germany

Klinikum Leverkusen; Med. Klinik III / Onkologie, Leverkusen, , Germany

Ludwig-Maximilians Uni Klinik Innenstadt; Medizinische Klinik, Muenchen, , Germany

St. James Hospital; Oncology, Dublin, , Ireland

Arcispedale Santa Maria Nuova; Oncologia, Reggio Emilia, Emilia-Romagna, Italy

IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST); Oncologia Medica A, Genova, Liguria, Italy

Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia, Milano, Lombardia, Italy

Az. Osp. S. Luigi Gonzaga; Malattie Apparato Respiratorio 5 Ad Indirizzo Oncologico, Orbassano, Piemonte, Italy

Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica, Sant'Andrea Delle Fratte (PG), Umbria, Italy

Medical University of Gdansk, Gdansk, , Poland

SK Przemienienia Panskiego UM im.K.Marcinkowskiego, Poznan, , Poland

Specjalistyczny Szpital Im. Prof. A. Sokolowskiego; Oddziall Chemioterapii, Szczecin, , Poland

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii, Warszawa, , Poland

Hospital Universitario Puerta de Hierro; Servicio de Oncologia, Majadahonda, Madrid, Spain

Hospital de Cruces; Servicio de Oncologia, Bilbao, Vizcaya, Spain

Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, , Spain

Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona, , Spain

Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Malaga, , Spain

Royal Surrey County Hospital; St. Lukes Cancer Centre, Guildford, , United Kingdom

Wythenshawe Hospital; North West Lung Centre, Manchester, , United Kingdom

Sir Bobby Robson Cancer Research Centre, Newcastle Upon Tyne, , United Kingdom

New Cross Hospital; Deansley Centre, Wolverhampton, , United Kingdom

Contact Details

Name: Clinical Trials

Affiliation: Hoffmann-La Roche

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: